查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363131

肠道疾病检测市场规模、份额和趋势分析报告：2023-2030 年按疾病类型、地区和细分市场分類的趋势

Enteric Disease Testing Market Size, Share & Trends Analysis Report By Disease Type (Bacterial Enteric Diseases, Viral Enteric Diseases, Parasitic Enteric Diseases), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

肠道疾病检测市场的成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球肠道疾病检测市场规模将达到46.8亿美元，2023年至2030年年复合成长率为2.7%。

在预测期内，对治疗霍乱和其他腹泻病等疾病的快速诊断的需求增加、由于生活条件不卫生而导致的人口老龄高龄化以及肠道疾病医学检测覆盖范围的扩大预计将推动市场的发展。

这种增长进一步归因于医疗保健支出的增加、政府的支持措施和疾病患病的增加。经济和环境要素，例如卫生条件差以及越来越多的人由于无法获得卫生食品和水供应而生活在贫困线以下，正在导致感染疾病罹患率上升，从而导致市场需求。正在促进增长。

根据比尔和梅琳达盖兹基金会的资料库，每年约有 50 万人因肠道疾病死亡，而且这一数字预计还会进一步上升。 75岁以上人口死亡率最高，其次是5岁以下儿童。

世界卫生组织和联合国儿童基金会等医疗保健联邦机构为有效管理病死率而采取的策略性倡议预计将推动市场成长。这些机构正在努力透过开展意识计划和医疗营来普及这些感染疾病的检测。我们也向第三世界国家的当地组织提供财政支持，以帮助减少这些感染疾病的传播。

肠道疾病检测市场报告亮点

  • 细菌性肠道疾病检测市场占据最大的收益占有率份额，由于这些感染疾病的高发病率，预计在 2023 年至 2030 年的预测期内将以最快的年复合成长率增长。根据约翰霍普金斯大学彭博公共卫生学院的研究，细菌感染引起的腹泻年度导致约 4 至 600 万人死亡。
  • 寄生虫肠道疾病检测市场预计将以 1.9% 的年复合成长率大幅成长。世界卫生组织估计，年度有超过 2 亿人感染蓝氏贾第虫、隐孢子虫和溶组织虫等寄生虫。
  • 由于老年人口增加、移民增加、患者意识层级提高以及相对较高的医疗成本，欧洲在 2022 年以 39.0% 的最大收益占有率主导市场。
  • 预计 2023 年至 2030 年预测期内，亚太地区将以 4.0% 的年复合成长率成长最快。日本、中国和印度等国家政府采取的提高意识和推动更高检测水准的配合措施预计将在预测期内推动市场发展。
  • 产业参与者不断透过新产品的推出和现有技术的升级来刺激市场。 2015 年 1 月，Biomerica 向美国专利商标局申请了一项用于检测胃肠道疾病的测试专利。
  • 除了技术创新之外，众多产业参与者也正携手合作，发挥各自优势，结成策略联盟，以获得更高的利润。例如，2017 年 5 月，Quest Diagnostics 宣布与 PeaceHealth 合作，透过高价值设计和创新来增强其服务。

目录

第1章调查方法与范围

第2章执行摘要

第3章疾病检测市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 肠道疾病检测市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章疾病检测市场：疾病类型预估及趋势分析

  • 肠道疾病检测市场，重点
  • 肠道疾病检测市场：2022 年和 2030 年趋势和市场占有率分析
  • 细菌性肠病
  • 病毒性肠疾病
  • 肠道寄生虫病

第5章疾病检测市场：区域估算及趋势分析

  • 区域展望
  • 按地区分類的肠道疾病检测市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第6章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
    • Abbott
    • BD
    • Biomerica
    • BIOMERIEUX
    • Bio-Rad Laboratories, Inc.
    • Cepheid
    • Coris BioConcept
    • DiaSorin SpA
    • Meridian Bioscience
    • Quest Diagnostics Incorporated
Product Code: GVR-1-68038-542-7

Enteric Disease Testing Market Growth & Trends:

The global enteric disease testing market size is expected to reach USD 4.68 billion by 2030, registering a CAGR of 2.7% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Increasing demand for rapid diagnosis in order to treat diseases such as cholera, and other diarrheal diseases, rise in the aging population accompanied by unhygienic living conditions, and growing application of medical testing for enteric diseases are expected to drive the market over the forecast period.

The growth is further attributed to rising healthcare expenditure, supportive government initiatives, and augmenting disease prevalence rate. Economic and environmental factors such as poor sanitation and the rising population living below the poverty line with no access to hygienic food and water supply are attributed to the growing incidence rate of the infections and thus propel the market growth.

According to the database of Bill and Melinda Gate Foundation, enteric diseases were responsible for about 500,000 deaths each year and these are anticipated to increase further. The highest mortality rate was observed amongst people above 75 years of age followed by children under 5 years of age.

Strategic initiatives by healthcare federal bodies such as the WHO and UNICEF, to manage the disease fatality effectively are expected to assist market growth. These agencies are working towards promoting widespread testing of people for such infections by conducting awareness programmes and healthcare camps. They also fund local agencies in third world countries to limit the spread of these infections.

Enteric Disease Testing Market Report Highlights:

  • Bacterial enteric disease testing market segment dominated with the largest revenue share and is also expected to grow at the fastest CAGR during the forecast period from 2023 to 2030 due to a higher occurrence of these infections. According to research conducted by Johns Hopkins Bloomberg School of Public Health, around four to six million people die annually due to bacterial infection-induced diarrhea.
  • The parasitic enteric disease testing market is expected to register significant growth with CAGR of 1.9%. The WHO has estimated over 200 million people to be infected annually by parasites such as giardia lamblia, cryptosporidium, and E. histolytica.
  • Europe dominated the market with the largest revenue share of 39.0% in 2022, owing to rising geriatric population base, increasing number of immigrants, and rising patient awareness levels coupled with relatively higher healthcare expenditures in the region.
  • Asia Pacific is expected to grow at the fastest CAGR of 4.0% over the forecast period from 2023 to 2030. Government efforts in countries such as Japan, China, and India to increase awareness and promote higher testing are expected to drive the market over the forecast period.
  • Industry players are constantly fueling the market with new product launches or upgrading the existing technology. In January 2015, Biomerica filed a patent application with the U.S. Patent and Trademark Office for a test used in the detection of gastrointestinal disorder.
  • Apart from technology innovation, many industry players are collaborating to use each other's strengths and are formulating strategic alliances in order to incur higher profits. For instance, in May 2017, Quest diagnostics announced a collaboration with PeaceHealth to enhance the service through high-value design and innovation.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Disease type
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Disease type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Enteric Disease Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Enteric Disease Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Enteric Disease Testing Market: Disease Type Estimates & Trend Analysis

  • 4.1. Enteric Disease Testing Market, Key Takeaways
  • 4.2. Enteric Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Bacterial Enteric Disease
    • 4.3.1. Bacterial enteric disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Viral Enteric Disease
    • 4.4.1. Viral enteric disease market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Rotavirus
      • 4.4.2.1. Rotavirus market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Norovirus
      • 4.4.3.1. Norovirus market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Parasitic Enteric Disease
    • 4.5.1. Parasitic enteric disease market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Enteric Disease Testing Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Enteric Disease Testing Market by Region: Key Takeaway
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Abbott
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. BD
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Biomerica
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. BIOMERIEUX
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Bio-Rad Laboratories, Inc.
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Cepheid
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Coris BioConcept
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. DiaSorin S.p.A.
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Meridian Bioscience
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Quest Diagnostics Incorporated
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 3 North America enteric disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 5 Canada enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 6 Europe enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 7 Europe enteric disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 9 UK enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 10 France enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 11 Italy enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 12 Spain enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 13 Sweden enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 14 Norway enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 15 Denmark enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific enteric disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 18 Japan enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 19 China enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 20 India enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 21 Australia enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 22 Thailand enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 23 South Korea enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 24 Latin America enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 25 Latin America enteric disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 27 Mexico enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 28 Argentina enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa enteric disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 33 UAE enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
  • Table 34 Kuwait enteric disease testing market, by disease type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Enteric disease testing: market outlook
  • Fig. 9 Enteric disease testing competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Enteric disease testing market driver impact
  • Fig. 15 Enteric disease testing market restraint impact
  • Fig. 16 Enteric disease testing market strategic initiatives analysis
  • Fig. 17 Enteric disease testing market: Disease type movement analysis
  • Fig. 18 Enteric disease testing market: Disease type outlook and key takeaways
  • Fig. 19 Bacterial enteric disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Viral enteric disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Rotavirus market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Norovirus market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Parasitic enteric disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Enteric disease testing market: Regional movement analysis
  • Fig. 25 Enteric disease testing market: Regional outlook and key takeaways
  • Fig. 26 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)